Is chemotherapy still needed in all patients with mismatch repair-deficient advanced or recurrent endometrial cancer?. // The Lancet. – URL: https://www.sciencedirect.com/science/article/pii/S0140673626021999?dgcid=rss_sd_all
Is chemotherapy still needed in all patients with mismatch repair-deficient advanced or recurrent endometrial cancer?. The Lancet. https://www.sciencedirect.com/science/article/pii/S0140673626021999?dgcid=rss_sd_all
“Is chemotherapy still needed in all patients with mismatch repair-deficient advanced or recurrent endometrial cancer?.” The Lancet.
@article{article68509,
title = {Is chemotherapy still needed in all patients with mismatch repair-deficient advanced or recurrent endometrial cancer?},
journal = {The Lancet},
url = {https://www.sciencedirect.com/science/article/pii/S0140673626021999?dgcid=rss_sd_all}
}
ABSTRACT As leadership education continues to evolve, increasing attention has been given to fostering learners’ leadership identity, capacity, and efficacy. Drawing on collaborative conversations with 12 leadership educators...